Pretreatment of cells with anti-DC-SIGN antibodies or with mannan, the natural ligand of DC-SIGN, as well as pretreatment of KSHV with soluble DC-SIGN has been shown to inhibit virus binding and infection [23,60]. The gene discussed is CD209; the disease is infection.